1 December 2015 - The final issue of the Schedule of Pharmaceuetical Benefits for 2015 sees the listing of several new medicines: aclidinium bromide with eformoterol fumarate dihydrate (Brimica Genuair), axitinib (Inlyta), brinzolamide with brimonidine tartrate (Simbrinza) & tiotropium hydrogen bromide with olodaterol hydrochloride (Spiolto Respimat).

For more details, go to: http://www.pbs.gov.au/browse/changes